This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Panitumumab after Resection of Liver Metastases fr...
Clinical trial

Panitumumab after Resection of Liver Metastases from Colorectal Cancer in KRAS Wild-type Patients -PARLIM-

Read time: 1 mins
Last updated:24th May 2011
The study aims to assess the efficacy of postoperative therapy with FOLFOX plus panitumumab followed by maintenance with panitumumab for 3 months in KRAS wild-type patients, compared to the historical data for standard FOLFOX chemotherapy alone, which are verified by a randomised control group without the antibody.
Category Value
Study start date 2011-05-24

View full details